In the context of TIG2, a protein involved in lipid metabolism and adipogenesis, identifying direct chemical activators is a complex task due to its intricate regulatory mechanisms and multifunctional nature. However, we can consider chemicals that indirectly influence TIG2 by modulating related metabolic and inflammatory pathways. These compounds, while not directly activating TIG2, could alter the cellular environment or regulatory networks in a way that benefits TIG2 function or expression. Compounds like Retinoic Acid and Vitamin D are notable for their role in gene expression and various metabolic processes. They could potentially impact the pathways regulating TIG2, either enhancing its expression or activity. PPAR agonists, including thiazolidinediones like Rosiglitazone and Pioglitazone, are particularly relevant given their role in adipocyte differentiation and lipid metabolism, processes closely associated with TIG2 function.
Additionally, metabolic modulators such as Metformin and Insulin, primarily known for their roles in glucose homeostasis, may also influence lipid metabolism and adipogenesis, thereby affecting TIG2 activity. Hormones like Leptin and Adiponectin, secreted by adipose tissue, play significant roles in energy balance and adipocyte function and could indirectly modulate TIG2's role in these processes. Furthermore, dietary components like Omega-3 Fatty Acids (Fish Oil) and phytochemicals such as Curcumin have anti-inflammatory properties. Their role in modulating inflammatory responses could be relevant for TIG2, considering its involvement in inflammation-related processes. These indirect activators offer a broader perspective on potential avenues to influence TIG2 function. By targeting related metabolic and inflammatory pathways, these compounds might create conditions that favor TIG2 activity or enhance its expression, providing insights into its role in adipogenesis, lipid metabolism, and inflammation. This approach is particularly valuable for exploring TIG2's function in physiological and pathological contexts, especially those related to metabolic health.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
A metabolite of Vitamin A that can influence gene expression, possibly impacting TIG2 expression or activity. | ||||||
Insulin | 11061-68-0 | sc-29062 sc-29062A sc-29062B | 100 mg 1 g 10 g | $156.00 $1248.00 $12508.00 | 82 | |
Influences adipogenesis and metabolic pathways, potentially modulating TIG2 activity. | ||||||
Metformin-d6, Hydrochloride | 1185166-01-1 | sc-218701 sc-218701A sc-218701B | 1 mg 5 mg 10 mg | $292.00 $822.00 $1540.00 | 1 | |
Primarily an antidiabetic drug, metformin can modulate metabolic pathways, potentially affecting TIG2. | ||||||
Rosiglitazone | 122320-73-4 | sc-202795 sc-202795A sc-202795C sc-202795D sc-202795B | 25 mg 100 mg 500 mg 1 g 5 g | $120.00 $326.00 $634.00 $947.00 $1259.00 | 38 | |
A PPAR gamma agonist that influences adipocyte differentiation, potentially affecting TIG2 expression. | ||||||
Cholecalciferol | 67-97-0 | sc-205630 sc-205630A sc-205630B | 1 g 5 g 10 g | $71.00 $163.00 $296.00 | 2 | |
Influences various metabolic processes, potentially impacting TIG2 activity or expression. | ||||||
Docosa-4Z,7Z,10Z,13Z,16Z,19Z-hexaenoic Acid (22:6, n-3) | 6217-54-5 | sc-200768 sc-200768A sc-200768B sc-200768C sc-200768D | 100 mg 1 g 10 g 50 g 100 g | $94.00 $210.00 $1779.00 $8021.00 $16657.00 | 11 | |
Known for their anti-inflammatory effects, may influence pathways related to TIG2 function. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $37.00 $69.00 $109.00 $218.00 $239.00 $879.00 $1968.00 | 47 | |
Exhibits anti-inflammatory properties, could modulate metabolic and inflammatory pathways affecting TIG2. | ||||||